Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
about
Topical n -docosanol for management of recurrent herpes labialisAcyclovir for treating varicella in otherwise healthy children and adolescentsAcyclovir for treating varicella in otherwise healthy children and adolescentsSlipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistanceAcyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials.Antiviral drug resistance: mechanisms and clinical implicationsConcomitant herpes simplex virus colitis and hepatitis in a man with ulcerative colitis: Case report and review of the literature.Antiviral selection in the management of acute retinal necrosis.Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system.Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group.Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models.Recent advances in management of genital herpes.Current recommendations for the treatment of genital herpes.Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementAnti-HSV activity of serpin antithrombin III.Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.Anti-herpes viruses agents.High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyLaser treatment of recurrent herpes labialis: a literature review.Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.Prevention and treatment of viral infections in stem cell transplant recipients.Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitroVerrucous herpes of the scrotum in a human immunodeficiency virus-positive man: case report and review of the literature.Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.Viruses, chemotherapy and immunity.Treatment of herpesvirus infections in HIV-infected individuals.Resistance of herpesviruses to antiviral drugsA net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.The use of antiviral drugs during the neonatal periodAcyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
P2860
Q22306022-45D75C99-2CA6-4260-ABE1-1AD0AD270678Q24245470-B0199AE3-0A6A-4572-A1FC-FF7CA7B4013BQ24247190-C919A269-308E-4036-890C-9BC41962E10CQ24634966-E062468D-D7CF-4AA1-92B8-EFA560A6F376Q24792309-C56632E0-6F1E-478D-8E7D-C9BCA61B14C6Q28282376-7E613DBF-D8D0-48BE-BF7E-559F951B53DEQ30244327-8F839C28-0F74-4CB7-A803-5849D23AC505Q33644146-E3B08D36-B673-4EC9-A8D6-283858A46C56Q33675654-26410E4F-F799-42C8-8F17-3D2C6546D99DQ33936909-3DFC7BE8-BB46-4FF1-8F60-534438BBBA8AQ33961421-0C84EA82-7843-41C7-BAD5-9C253A5C4B73Q33966906-9B9E95DC-6B0D-4AFC-91B3-BE86408386C7Q33976296-6AD2FA80-760F-4959-B871-126F3016DE19Q33978415-E265C7B8-BF1A-4D85-A6E2-F370EE90F81CQ33980794-D090AD47-F4FA-47B1-AC7B-06F5B400BB7CQ34012149-99229544-B23D-42DB-9D49-657A296E6CC0Q34127423-06BC2DC5-E5D1-49BE-911F-E4AB3E23A202Q34149904-36910576-330E-4539-BE64-274771871419Q34152714-FB49E464-6BB3-4956-82D6-90BCF6E1C1ABQ34290117-C229DBE3-0D23-4191-9D26-6E080AE8FA3DQ34344421-CDE10604-93E7-4243-8DDB-16D580C24816Q34467256-AAC0AF66-12E7-434F-80BC-C20ABDB8334CQ34579981-237D51C0-F642-4DCE-8834-D0170AFA62DEQ34667436-A4797FC1-D765-4F57-A683-0DF541C1F647Q34716802-ECFBD940-8547-46F5-AE6F-D4E1D8913C82Q34722706-DD016177-AE45-4800-BB2D-3CE95B80AB80Q34861045-0DF0E593-A8E5-41A5-96E4-0646EA5BA551Q34918273-02846D26-DFAF-43E9-9E40-5C9C985900EEQ34938781-46AA64F6-A041-4D8E-8C62-F71F5D95CD29Q34959913-A76CAC93-F1E0-4F5E-8817-BF971CE083A1Q34995157-88C00952-CC80-4744-B045-4BA1C85EA75CQ35115200-2577EF8A-CDCA-4DE8-8468-7EE9E1CDC690Q35172760-0C690695-8B8D-419F-A76A-361C219B031FQ35231928-4B4B76D9-4DF2-43BA-AC2A-5B019F24DCF3Q35447500-7A239B45-E17F-42A4-BB68-C343D1C854E3Q35462273-21C2036A-53D4-4C4D-A2D4-96915C43B65DQ35551858-80A2670D-9749-4C01-B83F-028FFC7AA5DEQ35789702-AC4143A1-C95D-4C89-9624-2E9FE17EBC61Q35809290-3CF8C22A-3A9F-4930-8254-B62BA5A8EFC4Q35821379-33F65C89-89C4-4D5A-A2EB-6C99670BD684
P2860
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@en
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@nl
type
label
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@en
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@nl
prefLabel
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@en
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@nl
P2093
P1476
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.
@en
P2093
Balfour HH Jr
Englund JA
Goodman JL
Swierkosz EM
Zimmerman ME
P304
P356
10.7326/0003-4819-76-3-112-6-416
P407
P577
1990-03-01T00:00:00Z